Workflow
股权激励计划
icon
Search documents
景旺电子: 景旺电子关于股权激励计划部分股票期权注销完成的公告
Zheng Quan Zhi Xing· 2025-06-18 10:33
Core Points - The company announced the completion of the cancellation of certain stock options and restricted stocks as part of its equity incentive plan [1][2] - A total of 165,000 shares of restricted stock and 145,200 stock options were subject to cancellation due to the departure of some incentive plan participants [1] - The cancellation of stock options was confirmed by the China Securities Depository and Clearing Corporation Shanghai Branch on June 17, 2025 [2] Summary by Sections - **Equity Incentive Plan**: The company held meetings on May 26, 2025, where it approved the repurchase and cancellation of certain restricted stocks and stock options as per its 2024 equity incentive plan [1] - **Details of Cancellation**: The company will repurchase and cancel 165,000 shares of restricted stock and 145,200 stock options that were granted but not yet exercised [1] - **Regulatory Compliance**: The cancellation process complies with the relevant regulations and will not affect the company's capital structure or financial performance [2] - **Management Commitment**: The management team remains committed to their responsibilities and aims to create value for shareholders despite the cancellations [2]
北京晶品特装科技股份有限公司关于收到公司实际控制人、董事长提议回购公司股份的提示性公告
证券代码:688084 证券简称:晶品特装 公告编号:2025-020 北京晶品特装科技股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 关于收到公司实际控制人、董事长提议 回购公司股份的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 北京晶品特装科技股份有限公司(以下简称"公司")于2025年6月13日收到公司实际控制人、董事长陈 波先生《关于提议回购公司股份的函》。现将提议主要内容公告如下: 一、提议回购股份的原因和目的 为践行"以投资者为本"的上市公司发展理念,维护公司全体股东利益,基于对公司未来发展前景的信 心、对公司价值的认可和切实履行社会责任,同时也为了完善公司长效激励机制,充分调动公司员工的 积极性,提高公司员工的凝聚力,促进公司长期健康发展,公司实际控制人、董事长陈波先生建议公司 以部分超募资金通过集中竞价交易方式实施股份回购,在未来适宜时机全部用于员工持股计划或股权激 励计划。 二、提议内容 1.回购股份的种类:公司发行的人民币普通股(A 股); 2.回购股份的用途:本次回购的股份将 ...
长华化学: 创业板上市公司股权激励计划自查表
Zheng Quan Zhi Xing· 2025-06-17 11:25
股权激励计划自查表 公司简称:长华化学 股票代码:301518 独立财务顾问(如有):无 长华化学科技股份有限公司 序号 事项 事项(是/否 备注 /不适用) 上市公司合规性要求 最近一个会计年度财务会计报告是否被注册会计师出具否 定意见或者无法表示意见的审计报告 最近一个会计年度财务报告内部控制被注册会计师出具否 定意见或者无法表示意见的审计报告 上市后最近36个月内出现过未按法律法规、公司章程、公开 承诺进行利润分配的情形 激励对象合规性要求 是否存在该 是否包括单独或者合计持有上市公司5%以上股份的股东或 是,是否说明前述人员成为激励对象的必要性、合理性 是否最近12个月内被中国证监会及其派出机构认定为不适 当人选 是否最近12个月内因重大违法违规行为被中国证监会及其 派出机构行政处罚或者采取市场禁入措施 是否具有《公司法》规定的不得担任公司董事、高级管理 人员情形 激励计划合规性要求 上市公司全部在有效期内的股权激励计划所涉及的标的股 票总数累计是否超过公司股本总额的20% 激励对象预留权益比例是否未超过本次股权激励计划拟授 予权益数量的20% 激励对象为董事、高级管理人员、单独或合计持股5%以上股 ...
川恒股份: 控股股东持股比例被动稀释触及1%整数倍的公告
Zheng Quan Zhi Xing· 2025-06-13 13:48
Core Viewpoint - The announcement details the passive dilution of the controlling shareholder's stake in Guizhou Chuanheng Chemical Co., Ltd. due to the implementation of an equity incentive plan, convertible bond conversions, and share repurchases, while confirming that the controlling shareholder and actual controllers remain unchanged [1]. Group 1: Shareholder Changes - The controlling shareholder, Sichuan Chuanheng Holding Group Co., Ltd., experienced a reduction in its shareholding from 51.22% to 50.55%, representing a passive dilution of 0.67% [1]. - The total share capital of the company increased from 542,035,745 shares to 539,944,451 shares due to the aforementioned corporate actions [1]. Group 2: Equity Incentive Plan - The company implemented a 2025 equity incentive plan, granting 9,232,400 shares, which contributed to the dilution of the controlling shareholder's stake [1]. - The conversion of convertible bonds resulted in the issuance of 1,289,612 shares, further impacting the shareholding structure [1]. Group 3: Shareholding Structure - The total number of shares held by the controlling shareholder remained unchanged at 277,634,700 shares, despite the dilution in percentage terms [1]. - The actual controllers, Li Jin and Li Guangming, continue to hold their positions without any changes [1].
深圳市雷赛智能控制股份有限公司 第五届董事会第十九次会议 决议公告
Core Viewpoint - Shenzhen Laisai Intelligent Control Co., Ltd. has made adjustments to its 2025 stock option and restricted stock incentive plan, including changes to grant prices and the list of incentive recipients due to voluntary withdrawals by some participants [1][4][8]. Group 1: Adjustments to Incentive Plan - The exercise price for stock options has been adjusted to 50.28 yuan per share, and the grant price for the first category of restricted stock has been set at 24.98 yuan per share [3][28]. - The number of incentive recipients has been reduced from 416 to 387, with the total number of granted stock rights remaining unchanged at 11,363,000 shares [4][30]. - The total number of stock options granted has been adjusted from 5,507,000 to 4,863,000, while the reserved options have increased from 493,000 to 1,137,000 [4][30]. Group 2: Approval and Implementation - The board of directors approved the adjustments to the incentive plan on June 11, 2025, with a unanimous vote of 5 in favor [6][7]. - The first grant date for the stock options and restricted stocks is set for June 11, 2025, with 486,300 stock options and 650,000 shares of restricted stock being granted to eligible recipients [6][24][57]. - The adjustments made to the incentive plan are within the authorization granted by the company's first extraordinary general meeting of 2025, thus not requiring further shareholder approval [5][8]. Group 3: Employee Stock Ownership Plan - The subscription price for the 2025 employee stock ownership plan has been adjusted from 37.95 yuan per share to 37.63 yuan per share [8][19]. - The board of directors has confirmed that the adjustments comply with relevant laws and regulations, ensuring no harm to the interests of shareholders [20][21].
通宇通讯: 上市公司股权激励计划自查表
Zheng Quan Zhi Xing· 2025-06-12 14:09
公司简称:通宇通讯 股票代码:002792 独立财务顾问:中国银河证券股份有限公司 | 是否存在该事 | | | | | --- | --- | --- | --- | | 序号 事项 项(是 | | 备注 | | | /否/不适 用) | | | | | 上市公司合规性要求 | | | | | 最近一个会计年度财务会计报告是否未被注册会计 | | 师出 | | | 具否定意见或者无法表示意见的审计报告 | | | | | 最近一个会计年度财务报告内部控制是否未被注册 | | 会计 | | | 师出具否定意见或无法表示意见的审计报告 | | | | | 上市后最近36个月内是否未出现过未按法律法规、 | | 公司 | | | 章程、公开承诺进行利润分配的情形 | | | | | 是否未为激励对象提供贷款以及其他任何形式的财 | | 务 | | | 资助 | | | | | 激励对象合规性要求 | | | | | 是否未包括单独或合计持有上市公司 5%以上股份的股东 | | | | | 是 | | | | | 是否最近12个月内未被中国证监会及其派出机构认定为 | | | | | 是 | | | | | 是否最 ...
中石科技: 创业板上市公司股权激励计划自查表
Zheng Quan Zhi Xing· 2025-06-12 13:25
公司简称:中石科技 股票代码:300684 独立财务顾问:上海荣正企业咨询服务(集团)股份有限 公司 是否存在该事 序号 事项 项(是/否/不 备注 适用) 上市公司合规性要求 最近一个会计年度财务会计报告是否被注册会计师出具否定意见或 者无法表示意见的审计报告 上市公司全部在有效期内的股权激励计划所涉及的标的股票总数累 计是否超过公司股本总额的 20% 激励对象预留权益比例是否未超过本次股权激励计划拟授予权益数 量的 20% 激励对象为董事、高级管理人员、单独或合计持股 5%以上股东或实 案是否已列明其姓名、职务、获授数量 股权激励计划披露完整性要求 最近一个会计年度财务报告内部控制被注册会计师出具否定意见或 者无法表示意见的审计报告 上市后最近 36 个月内出现过未按法律法规、公司章程、公开承诺进 行利润分配的情形 激励对象合规性要求 是否包括单独或者合计持有上市公司 5%以上股份的股东或者实际控 员成为激励对象的必要性、合理性 最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行 政处罚或者采取市场禁入措施 是否具有《公司法》规定的不得担任公司董事、监事、高级管理人 员情形 激励计划合规性要求 ...
美的集团: 北京市嘉源律师事务所关于美的集团第五期股权激励计划注销到期未行权期权相关事项的法律意见书
Zheng Quan Zhi Xing· 2025-06-12 12:30
Core Viewpoint - The legal opinion letter from Beijing Jiayuan Law Firm confirms the legality and compliance of Midea Group's cancellation of unexercised stock options under its fifth equity incentive plan, following the necessary approvals and procedures [1][2][3][4]. Group 1: Approval and Authorization - Midea Group has completed the necessary procedures for the cancellation of unexercised stock options, including the approval of relevant proposals at the board meeting [2][3]. - The company has provided all required original documents and materials to the law firm for review, ensuring their authenticity and completeness [2]. Group 2: Cancellation Details - As of the date of the legal opinion, a total of 85,000 stock options granted to 8 incentive targets under the fourth exercise period of the fifth equity incentive plan have expired and will be canceled [3][4]. - The cancellation aligns with the provisions of the management measures and the company's equity incentive plan [4]. Group 3: Conclusion - The legal opinion concludes that the cancellation of the stock options is in accordance with the relevant laws and regulations, confirming its legality and validity [4].
Intellia Therapeutics(NTLA) - 2025 FY - Earnings Call Transcript
2025-06-11 14:00
Financial Data and Key Metrics Changes - The meeting reported that proxies were received for approximately 80% of the total shares entitled to vote, indicating strong shareholder engagement [7]. Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting [16]. Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting [16]. Company Strategy and Development Direction and Industry Competition - The company proposed the approval of the 2025 equity incentive plan, indicating a focus on aligning executive compensation with long-term performance [10][15]. Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during the meeting [16]. Other Important Information - All proposals presented at the meeting were approved, including the election of directors and the ratification of the independent accounting firm [14][15]. Q&A Session Summary Question: Were there any questions submitted during the meeting? - There were no questions appropriately related to the purpose of this meeting [16].
民生健康(301507) - 投资者关系活动记录表2025-005
2025-06-09 00:54
Group 1: Company Overview - The company introduced its professional medical beauty brand "肌素然," focusing on peptide skincare products, including medical repair masks and gels [2][3] - The sales strategy for the new brand includes establishing sample stores in selected offline pharmacies and offering skin testing and consultation services [3] Group 2: Probiotics Product Strategy - The probiotics product line includes powders and functional foods, with a focus on fat-reducing and mood-regulating strains for promotion this year [3] - Sales channels for probiotics include offline pharmacies and online platforms, particularly targeting new retail platforms like Douyin and Kuaishou [3] Group 3: Market Insights and Strategies - The market size for smoking cessation products is challenging to assess, but there is a recognized demand that requires further consumer education [4] - The company plans to utilize innovative communication methods for health education to boost consumer purchases [4] Group 4: Product Launch and Stock Buyback - The minoxidil topical solution is expected to launch in Q3 2025, with a focus on effective marketing strategies due to high market demand [5] - The company has repurchased approximately 1.08 million shares out of a planned 1.3 to 1.45 million shares by the end of May 2025 [5] Group 5: Incentive Plans - The company is considering a new round of equity incentive plans to attract new teams and personnel, focusing on direct rewards and incentives for new projects [5]